Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Régis Lassalle"'
Autor:
Patrick Blin, Michael Joubert, Patrick Jourdain, Philippe Zaoui, Estelle Guiard, Dunia Sakr, Caroline Dureau-Pournin, Marie-Agnès Bernard, Régis Lassalle, Florence Thomas-Delecourt, Sébastien Bineau, Nicholas Moore, Cécile Droz-Perroteau
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Myocardial infarction (MI), stroke, peripheral arterial disease (PAD), heart failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases (CVRD) manifestations for type 2 diabetes. The objective was to es
Externí odkaz:
https://doaj.org/article/962f6525aefe43059d6a0b80c4891f8c
Autor:
Roméo Baulain, Jérémy Jové, Dunia Sakr, Marine Gross‐Goupil, Magali Rouyer, Marius Puel, Patrick Blin, Cécile Droz‐Perroteau, Régis Lassalle, Nicolas H. Thurin
Publikováno v:
Cancer Innovation, Vol 2, Iss 1, Pp 52-64 (2023)
Abstract Background Healthcare pathways of patients with prostate cancer are heterogeneous and complex to apprehend using traditional descriptive statistics. Clustering and visualization methods can enhance their characterization. Methods Patients wi
Externí odkaz:
https://doaj.org/article/130af1275cde4c11a7b8a0db5af7281e
Autor:
Pauline Bosco‐Lévy, Karine Briot, Nadia Mehsen‐Cetre, James O'Kelly, Gaëlle Désaméricq, Abdelilah Abouelfath, Régis Lassalle, Angela Grelaud, Adeline Grolleau, Patrick Blin, Cécile Droz‐Perroteau
Publikováno v:
JBMR Plus, Vol 7, Iss 9, Pp n/a-n/a (2023)
ABSTRACT Although drugs for osteoporosis have been demonstrated to be effective in reducing fracture risk in placebo‐controlled clinical trials, data on effectiveness in real‐world practice is limited. Data from the French national health insuran
Externí odkaz:
https://doaj.org/article/02a2438e50814933a76f58e93cf597f2
Autor:
Patrick Blin, Patrice Darmon, Patrick Henry, Estelle Guiard, Marie-Agnès Bernard, Caroline Dureau-Pournin, Hélène Maizi, Florence Thomas-Delecourt, Régis Lassalle, Cécile Droz-Perroteau, Nicholas Moore
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
Abstract Aim and hypotheses The THEMIS randomized trial compared ticagrelor plus aspirin versus placebo plus aspirin for patients with stable coronary artery disease and type 2 diabetes mellitus (CAD-T2DM), and without prior myocardial infarction (MI
Externí odkaz:
https://doaj.org/article/ad92aa4d41ef458d8ee27316b77cfc3f
Autor:
Nicolas H. Thurin, Pauline Bosco-Levy, Patrick Blin, Magali Rouyer, Jérémy Jové, Stéphanie Lamarque, Séverine Lignot, Régis Lassalle, Abdelilah Abouelfath, Emmanuelle Bignon, Pauline Diez, Marine Gross-Goupil, Michel Soulié, Mathieu Roumiguié, Sylvestre Le Moulec, Marc Debouverie, Bruno Brochet, Francis Guillemin, Céline Louapre, Elisabeth Maillart, Olivier Heinzlef, Nicholas Moore, Cécile Droz-Perroteau
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Diagnosis performances of case-identifying algorithms developed in healthcare database are usually assessed by comparing identified cases with an external data source. When this is not feasible, intra-database validation can prese
Externí odkaz:
https://doaj.org/article/b646fee260fb4045b7393d9f32eccf3c
Autor:
Patrick Blin, Pascal Demoly, Martine Drouet, Bruno Falissard, Séverine Lignot-Maleyran, Hélène Maizi, Simon Lorrain, Régis Lassalle, Cécile Droz-Perroteau, Nicholas Moore, Mathieu Molimard
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 14, Iss 1, Pp 1-11 (2018)
Abstract Background Allergic rhinitis affects around one quarter of the Western European population. Prophylactic allergen immunotherapy may be useful to reduce the risk of acute symptomatic attacks (hayfever). A five-grass pollen extract sublingual
Externí odkaz:
https://doaj.org/article/716fcc7f75b24a96a54b9dc42242a49d
Autor:
Nicolas H. Thurin, Jérémy Jové, Régis Lassalle, Magali Rouyer, Stéphanie Lamarque, Pauline Bosco-Levy, Corentin Segalas, Sebastian Schneeweiss, Patrick Blin, Cécile Droz-Perroteau
Publikováno v:
Journal of Clinical Epidemiology
Journal of Clinical Epidemiology, 2023, 155, pp.31-38. ⟨10.1016/j.jclinepi.2023.01.002⟩
Journal of Clinical Epidemiology, 2023, 155, pp.31-38. ⟨10.1016/j.jclinepi.2023.01.002⟩
International audience; Background and Objectives: Some medications require specific medical procedures in the weeks before their start. Such procedures may meet the definition of instrumental variables (IVs). We examined how they may influence treat
Autor:
Nicolas Thurin, Angela Grelaud, Adeline Grolleau, Marie-Agnès Bernard, Emmanuelle Bignon, Patrick Blin, Régis Lassalle, Cécile Droz-Perroteau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::add84428688805cb5af441c61ddad11d
https://doi.org/10.22541/au.168252889.94358955/v1
https://doi.org/10.22541/au.168252889.94358955/v1
Autor:
Nicholas Moore, Patrick Blin, Jochen Dress, Antje Timmer, Jacques Benichou, Jonas Reinold, Ron M.C. Herings, Edeltraut Garbe, Ingvild Odsbu, Susana Perez-Gutthann, Nuria Saigi-Morgui, Gunnar Toft, Vera Ehrenstein, Cécile Droz-Perroteau, Andreas J. Bircher, D. S. Rampton, Michael Forstner, Carla Franzoni, Elisabeth Smits, Joan Fortuny, Régis Lassalle, Katherine Rascher, Gero von Gersdorff, Mathias Schaller, Kenneth J. Rothman, Jetty A. Overbeek, Tania Schink, Marie Linder, Bianca Kollhorst, Lawrence Rasouliyan, Lia Gutierrez
Publikováno v:
Pharmacoepidemiology and Drug Safety
Pharmacoepidemiology and Drug Safety, Wiley, 2021, ⟨10.1002/pds.5319⟩
Pharmacoepidemiology and Drug Safety, 30(10), 1447-1457. John Wiley and Sons Ltd
Intravenous Iron Consortium 2021, ' Use of intravenous iron and risk of anaphylaxis : A multinational observational post-authorisation safety study in Europe ', Pharmacoepidemiology and Drug Safety, vol. 30, no. 10, pp. 1447-1457 . https://doi.org/10.1002/pds.5319
Pharmacoepidemiology and Drug Safety, Wiley, 2021, ⟨10.1002/pds.5319⟩
Pharmacoepidemiology and Drug Safety, 30(10), 1447-1457. John Wiley and Sons Ltd
Intravenous Iron Consortium 2021, ' Use of intravenous iron and risk of anaphylaxis : A multinational observational post-authorisation safety study in Europe ', Pharmacoepidemiology and Drug Safety, vol. 30, no. 10, pp. 1447-1457 . https://doi.org/10.1002/pds.5319
International audience; PURPOSE: This post-authorisation safety study estimated the risk of anaphylaxis in patients receiving intravenous (IV) iron in Europe, with interest in iron dextran and iron non-dextrans. Studies conducted in the United States
Autor:
Régis Lassalle, E. Bignon, Antonio Sa Cunha, Nicholas Moore, Pernelle Noize, Alain Monnereau, Eric Francois, Annie Fourrier-Réglat, Magali Rouyer, Jérémy Jové, Cécile Droz-Perroteau, Denis Smith
Publikováno v:
British Journal of Clinical Pharmacology. 87:1120-1128
AIMS Poor efficacy has been reported for patients with BRAF mutations for metastatic colorectal cancer (mCRC). METHODS EREBUS is a French cohort study of wild-type (wt) KRAS unresectable mCRC patients initiating a first-line treatment with cetuximab